• 제목/요약/키워드: Beevenom

검색결과 9건 처리시간 0.023초

봉독약침액(蜂毒藥鍼液)에 의한 인체유방암세포(人體乳房癌細胞)의 성장억제(成長抑制) 및 세포사(細胞死)에 관한 연구(硏究) (Induction of the Growth Inhibition and Apoptosis by Beevenom in Human Breast Carcinoma MCF-7 Cells)

  • 여성원;서정철;최영현;장경전
    • Journal of Acupuncture Research
    • /
    • 제20권3호
    • /
    • pp.45-62
    • /
    • 2003
  • Objective : To examine the effects of Beevenom on the cell proliferation of human breast carcinoma cell line MCF-7, we performed various experiments such as does-dependent effect of Beevenom on cell proliferation and viability, morphological changes, and alterations of apoptosis/cell cycle-regulatory gene products. Methods : Beevenom induced cell viability and proliferation of MCF-7 cells in a concentration-dependent manner. The anti-proliferative effect by Beevenom treatment in MCF-7 cells was associated with morphological changes such as membrance shrinking and cell rounding up. Results : Beevenom induced apoptotic cell death in a concentration-dependent manager, which was associated with degradation of ${\beta}$-catenin, an apoptotic target protein. Beevenom induced the Bax expressions, a pro-apoptotic gene, both in protein and mRNA levels, however, the levels of Bcl-$X_{S/L}$ expression, an anti-apoptotic gene, were down-regulated in Beevenom-treated cells. Western blot analysis and RT-PCT data revealed that the levels of cyclin of B1 protein and cyclin E mRNA were reduced by Beevenom treatment in MCF-7 cells, respectively, where as the expression of tumor suppressor p53 and cyclin dependent kinase inhibitor p21 mRNA were markedly increased in a concentration-dependent fashion. Conclusions : Taken together, these findings suggest that Beevenom induced inhibition of human breast cancer cell proliferation is associated with the induction of apoptotic cell death and Beevenom may have therapeutic potential in human breast cancer.

  • PDF

미세피부침, 절개침법과 봉독 약침 복합 요법의 여드름 흉터 치료 27례 임상 보고 (Clinical Study of Twenty-seven Case of Treating Acne scar Using Microneedle Therapy and Subcision Combined with Beevenom Pharmacopuncture Therapy)

  • 김혜윤;홍석훈;박인해;허은선;노현민;신선호
    • 한방안이비인후피부과학회지
    • /
    • 제28권3호
    • /
    • pp.101-113
    • /
    • 2015
  • Objectives : Microneedle therapy and Subcision are commonly used for therapeutic modalities of acne scars in Korean medicine. Beevenom could promote the expression of various cytokines, enzymes and receptors related to increasing collagen content of connective tissues. Through this mechanism, we considered that Beevenom pharmacopuncture therapy is applicable to the treatment of acne scars. We investigated twenty-seven patients with acne scars treated by Microneedle therapy and Subcision combined with Beevenom pharmacopuncture therapy and evaluated the clinical effect.Methods : Twenty-seven patients with acne scars were treated by Microneedle therapy and Subcision combined with Beevenom pharmacopuncture therapy and evaluated the clinical effect. for twelve weeks. The severity of acne scars and treatment effect were evaluate by standardized photography, GASC, ECCA scale and patient`s satisfaction. And side effects was also checked.Results : After twelve weeks for treatment, there was an improvement in GASC, ECCA scale. 77.8% of patient replied excellent or good on patient satisfaction survey. One patient sufferied from pruritus, papules and comedones as side effect of treatment.Conclusion : It can be considered that Microneedle, Subcision, Beevenom pharmacopuncture combining therapy are effective method for treating acne scars.

원형탈모로 시작된 전신형탈모 환자에 대한 봉독약침 효과에 관한 임상증례보고 (A Case Study of Beevenom Effect on Alopecia Universalis Started from Alopecia Areata)

  • 이승원;고정민;이소영;이민호;김영진;이승훈;유승연;정지윤;권효정;이윤호
    • Journal of Acupuncture Research
    • /
    • 제25권6호
    • /
    • pp.163-173
    • /
    • 2008
  • Objectives : The purpose of this study is to see the effect of beevenom on inhibition of Alopecia Universalis. Methods : Beevenom was injected subcutaneously through the borderline of head scalp alopecia starting and, also, region feeling stiff tension. Results : Hair falling off seized and scalp tension was vanished. Conclusions : Beevenom seemed to inhibit the progression of Alopecia by recirculating the blood flow as stiff tension over head was solved and anti-inflammatory effect of beevenom seizing inflammation on the scalp. Further evaluation with big sample size control study would be required to manifest the rationale and effectness of Beevenom over Alopecia Universalis.

  • PDF

봉독 면역요법후의 면역학적 변화에 대한 고찰 -알레르기 질환에 응용 가능성을 중심으로- (Immunological Changes on Allergic Response after Beevenom Immunotherapy)

  • 한동하
    • 대한약침학회지
    • /
    • 제7권3호
    • /
    • pp.27-35
    • /
    • 2004
  • Beevenom immunotherapy(BVIT) in allergic patients is a well-established treatment modality for the prevention of systemic anaphylactic reactions caused by insect stings. BVIT is accompanied by increases in allergen-specific IgG, particularly the IgG4 isotype, which blocks not only IgE-dependent histamine release from basophils but also IgE-mediated antigen presentation to T cells. Inhibition of T cells after BVIT also involves decreased induction of the costimulatory molecule ICOS, which, in turn, seems to be dependent on the presence of IL-10, also associated with the inhibited status of T cells after BVIT. Suppression of T cells by IL-10 is an active process, which depends on the expression and participation of CD28. Immune tolerance in specific allergen immunotherapy might be a consequence of decreased Th2 or increased Th1 response of allergen specific T lymphocytes. BVIT shifted cytokine responses to allergen from a TH-2 to a TH-1 dominant pattern, suggesting direct effects on T cells. Many studies showed that severe side effects due to venom immunotherapy are rare. These results suggest that immunological changes after BVIT may be applied to be therapeutic alternative of general allergic diseases including beevenom allergy.

외상성 상완신경총 환자 1례에 대한 한의학적 임상증례보고 (Clinical Study on the Case of Patient with Traumatic Brachial Plexus Injury)

  • 최이정;신화영;김성진;이용은;이봉효;이윤규;김재수;이현종;권효정;정태영;임성철
    • Journal of Acupuncture Research
    • /
    • 제29권2호
    • /
    • pp.99-106
    • /
    • 2012
  • Objectives : The purpose on this study is to report clinical effects of oriental medicine for traumatic brachial plexus injury. Methods : The patient was treated using acupuncture, electroacupuncture, beevenom acupuncture treatment, herbal medication, moxibustion and physical treatment. And the effects for traumatic brachial plexus injury have measured in VAS, sthenometry and dermatome of upper limb. Results : 1. VAS of upper limb pain was changed to go down at less than half. 2. Sthenometry was improved slowly than VAS. 3. Dermatome of upper limb were improved gradually. Conclusions : Oriental medical treatment showed positive effect on traumatic brachial plexus injury.

요추 추간판 탈출증 수술 실패 증후군 환자레 대한 보존적 치료 치험 1례 (The Case Report of Conservative Treatment on Failed Back Surgery Syndrome)

  • 홍순성;진은석
    • 척추신경추나의학회지
    • /
    • 제4권2호
    • /
    • pp.163-172
    • /
    • 2009
  • Objectives : The purpose of this study is to evaluate the conservative treatment for FBSS patient. Method : We used Acupuncture, Beevenom, CHUNA manual therapy, Herbal medication, for this patient. And we measured of VNRS and ODI score to evaluate the conservative treatment effects. Result : Patient's LBP & Rt.leg pain VNRS and ODI score were decreased.

  • PDF

$\ll$ 한침구학회지$\gg$, $\ll$대한침구학회임상논문집$\gg$ 게재 논문 중 한방치료의 이상반응 보고사례에 대한 고찰 (Review of Papers on Adverse Events in the Course of Oriental Medical Treatments in the Journal of Korean Acupuncture & Moxibustion Society(JKAMS) and the Journal of Clinical Thesis Korean Acupuncture & Moxibustion Society(JCTKAM))

  • 김동혁;서창완;백용현;이재동;최도영
    • Journal of Acupuncture Research
    • /
    • 제28권1호
    • /
    • pp.45-63
    • /
    • 2011
  • Objectives : The aim of this study is to review papers on adverse events in the course of Oriental Medical treatments in the JKAMS and the JCTKAM. Methods : We searched papers up to December 2010 in the JKAMS and The JCTKAM. Electronic and manual literature searches were performed. Results : 92 papers were retrived in total. Out of these, 62 reported the occurrence of adverse events whereas 30 reported none. Adverse events in treatments were generally transient and mild. However, this result had limitations due to the insufficient number of papers reporting adverse events and the inconsistency in the methodology according to each paper. Conclusions : Reports on adverse events are necessary in clinical research. In future research, organized case reports and systemic reviews should be carried out. Furthermore, prospective studies should be done as well.

Beevenom 처리가 돼지의 체내 면역반응에 미치는 효과 (Effects of Natural Honeybee (Apis mellifera ligustica) Venom Treatment on the Humoral Immune Response in Pigs)

  • 조성구;김경수;이석천
    • Journal of Animal Science and Technology
    • /
    • 제48권6호
    • /
    • pp.933-942
    • /
    • 2006
  • 본 실험은 생봉독 처리가 돼지의 체액성 면역반응에 대한 생봉독의 효과를 조사하기 위하여 실시하였다. 혈중 Immunoglobulin(Ig) G, IgA, IgM의 농도에 미치는 생봉독의 효과를 조사하기 위하여 모돈 3두에서 생산한 자돈 20두(LY ×D)를 생봉독 처리군과 대조군으로 각각 10두씩 배치하였다. 생봉독 처리군은 출생시와 3일령에 교소혈 (GV-1), 해문혈(ST-25) 및 두구혈(CV-8), 6일령에 거세, 단미 창상부위에 생봉 1마리씩 직침 시술하였고, 대조군은 생리식염수 1ml를 동일한 혈위에 주입하였다. 혈중 Ig 농도 측정을 위하여 출생시와 3일, 7일, 14일 및 21일령에 채혈하여 Immunoturbidimetric method로 IgG, IgM, IgA를 측정하였다. 지표항원으로 사용한 돈 콜레라와 위축성비염 백신에 대한 생봉독의 항체 생성효과를 조사하기 위하여 모돈 5두에서 생산된 자돈 40두(LY×D)를 생봉독 처리군과 대조군으로 각각 20두씩 공시하였다. 생봉독 처리군은 출생시에 교소혈(Jiao-Chao, GV-1), 해문혈(Hai-Men, ST-25) 및 두구혈(Du-Kou, CV-8)에, 3일령에 단미 및 거세시술 시 창상부위에 생봉독을 처리하였고, 21일령 이유시에는 교소혈(GV-1)과 백회혈(Bai- Hui, GV-20)에 생봉독을 처리하였다. 지표항원으로 위축성비염 백신은 24일령과 44일령에 접종하였고 돈콜레라 백신은 44일령과 64일령에 각각 접종하였다. 항체가 분석용 혈액은 24, 34, 44, 54 및 74일령에 채혈하여 위축성비염은 시험관응집반응, 돈콜레라는 ELISA법에 의하여 항체가를 조사하였다. IgG 농도는 처리군에서 출생시 339.52, 3일령에 366.48, 7일령에 296.52, 14일령에 242.06, 21일령에는 219.06mg/dl이었고 대조군은 각각 347.10, 333.14, 243.28, 205.18 및 191.58mg/dl 이었다. 처리전(출생시)에는 처리군과 대조군간에 유의차가 없었으나 처리군의 IgG 농도가 대조군에 비하여 3일령 10.3% (P<0.02), 7일령에는 21.9% (P<0.01), 14일령에는 18.0% (P<0.07), 21일령에는 14.3(P<0.07) 더 높게 나타났다. IgA와 IgM의 농도는 전체기간동안 처리군과 대조군간에 유의차가 인정되지 않았다. 돈콜레라 virus에 대한 항체역가는 처리군에서 대조군에 비하여 24일령 때 57.0%(P<0.03), 34일령 때 74.6% (P<0.006), 44일령에 48.6% (P<0.017), 54일령 때 45.0% (P<0.16), 74일령 때 44.4%(P<0.006)가 유의하게 높은 것으로 나타났다. 위축성비염 원인균인 Bordetella bronchiceptica에 대한 항체역가는 처리군이 대조군에 비하여 34일령 때는 39.7%(P<0.002), 44일령 때 31.9% (P<0.02), 54일령 때에 33.4%(P<0.01), 74일령 때에는 57.3%(P<0.007)가 높게 나타나 접종일인 24일령을 제외하고 전체기간에 걸쳐 높은 항체수준을 보였다. 위의 결과를 종합해 볼 때 돼지에 대한 생봉독 처리는 면역기능향상 효과가 있는 것으로 사료된다. 이와 같은 결과를 볼 때 돼지에 대한 생봉독의 처리는 양돈 생산성면에서 생봉독 처리는 돼지의 생존율을 높이고, 증체량이 높았다는 조 등(2005)의 보고를 뒷받침하고 있어 양돈 산업발전에 기여할 것으로 사료된다.

암에 대한 약침치료의 국내 동물모델 연구 현황 (The Current Research Methodology of Pharmacopucture for the Treatment of Animal Cancer Models in Korea)

  • 유희경;구본혁;석경환;이주현;류수형;이수연;김민정;박연철;백용현;박동석;서병관
    • Journal of Acupuncture Research
    • /
    • 제31권4호
    • /
    • pp.81-97
    • /
    • 2014
  • Objectives : The purpose of this study is analyzing the current research methodology of pharmacopucture for the treatment of animal cancer models. Methods : Four electronic databases were searched for animal studies published from January 2000 to September 2014 onward using these search terms "cancer, anticancer, pharmacopuncture, beevenom". Selected articles were described about animal cancer models. The methods used to induce cancer and the outcome measures used to assess the effects of pharmacopuncture on animal cancer models were analyzed. Results : 37 articles were included. For producing animal cancer models BALB/C mice(n=22) and C57BL/6 mice(n=17) were selected. And intravenous injection of B16-F10 melanoma cells into tail vein(n=14) or intraperitoneal injection of sarcoma-180 cells(n=14) were frequently used to induce cancer. Various pharmacopunctures were injected into acupoints $CV_{12}(n=19)$, $ST_{36}(n=8)$, $BL_{18}(n=8)$ or peritoneal cavity(n=6), tumor site(n=2), tail vein(n=2). Outcome measures were categorized into anti-cancer, anti-metastasis, general condition, cytotoxicity, immune response, toxicity. Median Survival Time(MST) and increase of life span(ILS)(n=26) was frequently used for evaluating anti-cancer effects. And pulmonary colonization assay(n=13) was frequently used for evaluating anti-metastasis effects Conclusions : Based on these data, further research would be needed to ascertain the effectiveness of pharmacopuncture for treating cancer and broaden the range of clinical applications.